Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Revenue

Shukra Pharmaceuticals had revenue of 399.50M INR in the quarter ending December 31, 2025, with 244.67% growth. This brings the company's revenue in the last twelve months to 645.69M, up 93.34% year-over-year. In the fiscal year ending March 31, 2025, Shukra Pharmaceuticals had annual revenue of 325.87M, down -56.30%.

• Revenue (ttm): 645.69M
• Revenue Growth: +93.34%
• P/S Ratio: 23.97
• Revenue / Employee: 5.61M
• Employees: 115
• Market Cap: 15.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	325.87M	-419.86M	-56.30%
Mar 31, 2024	745.73M	150.80M	25.35%
Mar 31, 2023	594.93M	390.07M	190.41%
Mar 31, 2022	204.86M	92.90M	82.97%
Mar 31, 2021	111.96M	-6.50M	-5.49%